IQVIA Holdings (IQVIA), a publicly owned company founded in 1982, is a global provider of services to the life sciences industry. Its offerings encompass advanced analytics, technology solutions, and clinical research services, primarily serving hospitals and healthcare organizations. The company employs approximately 72,660 people and is headquartered in the United States.
In 2023, Iqvia reported a shift in decision-making within the U.S. healthcare industry, with integrated networks such as GPOs, IDNs, and payers gaining more influence compared to individual physicians. This change has led to an increased emphasis on demonstrating the value of medical device and diagnostic solutions, with demands for outcomes analyses and pricing pressures. Additionally, Zacks revealed a report identifying potential growth stocks, including Iqvia Holdings Inc. (IQV), while RFP Financial Group held a minimal 0.00% stake in the company. Furthermore, a research report on the pharmacovigilance market provided insights into market size, regional shares, competitors, and detailed market share analysis.
Subscribe for full access to Iqvia's products in full detail 
